Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Market Cap

Tianjin Pharmaceutical Da Ren Tang Group Corporation has a market cap or net worth of 23.65 billion as of October 11, 2024. Its market cap has increased by 3.06% in one year.

• Market Cap: 23.65B
• Enterprise Value: 21.26B
• Revenue: 8.10B
• Ranking: n/a
• PE Ratio: 29.91
• Stock Price: 35.65

Market Cap Chart

Since June 6, 2001, Tianjin Pharmaceutical Da Ren Tang Group Corporation's market cap has increased from 6.92B to 23.65B, an increase of 242.05%. That is a compound annual growth rate of 5.41%.

Market Cap History

Date	Market Cap	% Change
Oct 10, 2024	23.65B	6.93%
Dec 29, 2023	22.12B	21.24%
Dec 30, 2022	18.25B	-6.30%
Dec 31, 2021	19.47B	73.88%
Dec 31, 2020	11.20B	23.50%
Dec 31, 2019	9.07B	9.70%